Abstract
Carbapenem resistance in Klebsiella pneumoniae is most notably due to the K. pneumoniae carbapenemase (KPC) β-lactamase. In this report, we describe the occurrence of a newly described mechanism of carbapenem resistance, the NDM-1 β-lactamase, in a patient who received medical attention (but was not hospitalized) in India.
Publication types
-
Case Reports
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged, 80 and over
-
Anti-Bacterial Agents / pharmacology*
-
Australia
-
Bacterial Typing Techniques
-
Carbapenems / pharmacology*
-
Female
-
Humans
-
India
-
Klebsiella Infections / microbiology
-
Klebsiella pneumoniae / classification
-
Klebsiella pneumoniae / drug effects*
-
Klebsiella pneumoniae / enzymology*
-
Klebsiella pneumoniae / genetics
-
Klebsiella pneumoniae / isolation & purification
-
Microbial Sensitivity Tests
-
Multilocus Sequence Typing
-
Urinary Tract Infections / microbiology
-
beta-Lactam Resistance*
-
beta-Lactamases / biosynthesis*
Substances
-
Anti-Bacterial Agents
-
Carbapenems
-
beta-Lactamases
-
beta-lactamase NDM-1